Real-time enrollment status for this progressive pulmonary fibrosis clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 3:08 PM UTC
| NCT Number | NCT06951217 |
| Recruiting Status | Recruiting |
| Condition | Progressive Pulmonary Fibrosis |
| Phase | PHASE2 |
| Target Enrollment | 340 participants |
| Active Locations | 26 sites in the US |
| Sponsor | Avalyn Pharma Inc. |
| Last Updated on CT.gov | August 7, 2026 (2 weeks ago) |
As of August 27, 2026: Clinical trial NCT06951217 is currently recruiting participants. This phase2 study for progressive pulmonary fibrosis is actively seeking new participants at 26 locations across the United States. The study is sponsored by Avalyn Pharma Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06951217 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 26 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06951217 was last updated 2 weeks ago (August 7, 2026). HelloStudys verifies this status automatically.